Status:
COMPLETED
Survey to Describe Impact of Reflux Disease on Everyday Life in GERD Patients Before and After 4 Weeks Treatment.
Lead Sponsor:
AstraZeneca
Conditions:
Gastroesophageal Reflux Disease
Eligibility:
All Genders
18+ years
Brief Summary
To describe the change of impact of reflux symptoms on the everyday life perceived by patients before and after 4 weeks treatment by using GERD Impact Scale questionnaire (GIS) by total GERD patient p...
Eligibility Criteria
Inclusion
- Patients with GERD diagnosed clinically or by endoscopy and prescribed with medical treatments
- Provision of written informed consent
Exclusion
- Patients cannot read and/or understand GIS
- Patients with the history or symptoms of peptic ulcer, gastrointestinal cancer, serious or malignant diseases (anorexia, weight loss, anemia, fever …)
Key Trial Info
Start Date :
October 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2009
Estimated Enrollment :
2091 Patients enrolled
Trial Details
Trial ID
NCT00786773
Start Date
October 1 2008
End Date
June 1 2009
Last Update
December 7 2010
Active Locations (18)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Long Xuyen, An Giang, Vietnam
2
Research Site
Qui Nhon, Binh Dinh, Vietnam
3
Research Site
Buon Ma Thuot, Dac Lac, Vietnam
4
Research Site
Biên Hòa, Dong Nai, Vietnam